Barely Significant
← all excerpts

Assessment of CD52 expression in "double-hit" and "double-expressor" lymphomas: Implications for clinical trial eligibility.

PLoS One · 2018 · PMC6051601 · PMID 30020951

Europe PMCDOI
1
hedged sentence
0.0990
closest p · 2.0× alpha
0.0990
boldest claim

The sentences

a slight trendP = 0.099so close (0.05 < p ≤ 0.1)
Within the DHL group, the presence or absence of BCL2 and/or BCL6 translocations showed no significant influence over CD52 expression, although there was a slight trend towards increased CD52 expression in the absence of BCL6 translocation [P = 0.099].

also in 4,078 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.